Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease

Kao KD, Troost JP, Yang JD, Salgia R, Woolen SA, Mehta N, Hoteit MA, Jalal PK, El Dahan KS, Daher D, Quirk L, Patel N,[...]

Ahn B, Wanagat J, Cleary C, Ainsworth HC, Kim H. Unacylated Ghrelin Counteracts Mitochondrial Dysfunction and Neuromuscular Junction Disruption in Cancer Cachexia. Am J Physiol[...]

Geng M, Riveros C, Shah YB, Ranganathan S, Fok K, Titus RS, Mundra V, Velasquez EL, Kaushik D, Detsky AS, Jerath A, Breyer BN, Tsugawa[...]